Committee of Experts on Quality and Safety Standards in Pharmaceutical Practices and Pharmaceutical Care (CD-P-PH/PC)

 

Programme Results 2008-2011

 

Surveys and reports prepared by experts in the field:

  • "Definitions of key concepts in pharmaceutical care, indicators for good quality of pharmaceutical care and services, existing source for relevant data/information".

  • "Impact of traditional (foreign) therapies on pharmaceutical practice in Europe: Traditional Chinese Medicine (TCM)".

Presentation and discussion of results to a larger audience composed of policy-makers (authorities) and relevant stakeholders concerned by the policies or practical programmes at workshop and conferences:

  • Expert Workshop on "Promoting standards for the quality and safety assurance of pharmacy-prepared medicinal products for the need of patients" (24 September 2009, Strasbourg). Forty-five participants from 21 Member States.

  • Expert Workshop on "Promoting pharmaceutical care in Europe through the assessment of the quality of pharmaceutical care practices in Europe" (19 November 2009, Strasbourg). Fifty-one participants from 22 Member States of the Council of Europe participated in the expert workshop.

  • Expert Workshop on the "Impact of Traditional Chinese Medicine in Europe" (28 October 2010, Strasbourg).

  • Expert Workshop on "Indicators for the assessment of the quality of pharmaceutical care in Europe: progress report" (10 December 2010, Strasbourg).


Policy formulation (proposals for resolutions)/development of programmes:

  • Committee of Ministers' Resolution CM/ResAP(2011)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patient (Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers' Deputies)

  • Survey report (2009): "Pharmaceutical Care in Europe: Where do we stand - where should we go?" (ISBN publication);

  • Development and piloting of 10-15 indicators for assessing the quality of pharmaceutical care in Europe through a network of 12 scientists based at 9 academic institutions:

    • 2-4 indicators for improving the safety of the medication use process through the appropriate use of data linkage using as example the use of antibiotics and anticoagulants in a hospital setting;
    • the development and piloting of a survey questionnaire about the current status of existence and use of data linkage in selected public pharmacies of selected 6 countries in Europe through the network of scientific collaborators of the EDQM coordinated Pharmaceutical Care working party;
    • development of a pharmaceutical care indicator checklist for pharmacies (self-assessment tool);
    • indicators for the quality of initial patient counselling, personalised written information and doctor's communication;
    • indicators in the fields of : achieving patient concordance at the start of new medication for a chronic condition through patient self-completion concordance (SCCF) forms (process indicator); recording of information contained in the SCCF forms through the establishment and use of a documentation system; development of a treatment plan in elderly patients > 65 years using more than 5 medicines a day for chronic conditions among different health professionals involved in pharmaceutical care;
    • indicators for the quality assessment of pharmaceutical care in regions in Europe with specific needs on either national and individual pharmacists' levels, namely for the availability of multidisciplinary professional standards for pharmaceutical care; the availability of information sources relevant for pharmaceutical care; the availability of pre-requisites for the implementation of the concept of pharmaceutical care and pharmacist's self-assessment as regards the level of implementation of the concept of pharmaceutical care in his professional activities and for pre-requisites thereof;
    • a Standard Operating Procedure for the projects in which the indicators are tested. The SOP will focus on the main criteria, which should be similar in order to : define the coordination process and ensure the comparability of those projects, therefore allowing the drawing of conclusions; provide basis process information for carrying out the testing of those pharmaceutical care indicators in a multinational and multi-stakeholder environment, such as that coordinated by the EDQM;
    • development of a user grid in flow-chart format as a tool to support decision making by professional associations and policy-makers when attempting the development of indicators for pharmaceutical care in their chosen settings in Europe; refine the "indicator development log book" (spreadsheet for monitoring indicator development and quality assurance check and assess for face and content validity.
  • Workshop Conclusions/Road Map for Activities - Expert Workshop on "Impact of Traditional Chinese Medicine in Europe" (in preparation);

  • Element of proposed specific programme of activities (2011-13): implementation, evaluation of impact of the results of the programme of activities 2008-2010 as specified in the Committee of Expert's terms of reference.

 

© European Directorate for the Quality of Medicines & HealthCare